Cardiovascular Diseases Clinical Trial
To examine genetic and environmental influences on several recently identified coronary heart disease risk factors in identical and fraternal adult women twins. The risk factors included low density lipoprotein (LDL) subclass patterns, plasma apolipoprotein levels, body fat distribution, and serum insulin levels.
BACKGROUND:
In 1974, a twin registry was established from members of the Kaiser Permanente Medical Care
Program's Northern California region. In all, 9,821 twin pairs were enrolled. In 1978-1979,
434 pairs of female twins were recruited from the registry for a clinical examination of
coronary heart disease risk factors. The clinical examination included an extensive health
questionnaire, measurements of plasma lipids and serum chemistries, analyses of genetic
markers for determination of zygosity, measurement of expired air carbon monoxide and serum
thiocyanate levels, and a complete physical examination. During the ten years since the
first examination, several new or more specific coronary heart disease risk factors have
been recognized, including low density lipoprotein and insulin levels, and the anatomic
distribution of body fat.
DESIGN NARRATIVE:
All women who participated in the first examination were invited to participate in the
second examination. Medical records and/or death certificates were obtained to document
coronary heart disease events. Questionnaires were used to collect information on health
history, nutrition, and physical activity. A clinical examination assessed blood pressure, a
variety of anthropometric measures and cardiovascular fitness. Blood specimens were
collected for clinical chemistry and lipid/lipoprotein profiles. To assess genetic
influence, the heritability of each of the risk factors was estimated. Blood was frozen for
future studies of polymorphic DNA markers. Using the monozygotic co-twin control method, the
effects of environmental or behavioral factors on these risk factors were assessed after
controlling for genetic factors that could explain their association. Two hypotheses were
examined that could be uniquely addressed using twin data. First, the association of body
fat distribution with other coronary heart disease risk factors was mediated by serum
insulin levels. Secondly, cardiovascular fitness explained in part the association of
physical activity with coronary heart disease risk factors such as HDL-cholesterol and
insulin levels. Lipoprotein analyses were conducted at Donner Laboratory at Berkeley.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|